Rapid Micro Biosystems financials
$1.08−1.37%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $8.0M | $11.3M | $7.8M | $7.3M | $7.2M | $8.2M | $7.6M | $6.6M | $5.6M | $6.3M | $6.1M |
| Gross profit | $1.2M | $371.0K | -$328.0K | $696.0K | $275.0K | $404.0K | $981.0K | $622.0K | -$189.0K | -$1.5M | -$172.0K | -$1.6M |
| Gross margin | 15.0% | 4.6% | −2.9% | 8.9% | 3.8% | 5.6% | 11.9% | 8.2% | −2.9% | −27.1% | −2.7% | −26.5% |
| Operating income | -$12.3M | -$13.9M | -$12.2M | -$11.4M | -$12.1M | -$11.7M | -$10.2M | -$12.0M | -$13.4M | -$14.3M | -$12.2M | -$14.4M |
| Net income | -$12.9M | -$14.3M | -$12.5M | -$11.5M | -$11.9M | -$11.3M | -$9.7M | -$11.3M | -$12.6M | -$13.3M | -$11.2M | -$13.4M |
| Net margin | −160.5% | −178.4% | −110.8% | −146.8% | −163.3% | −156.3% | −117.6% | −148.9% | −190.1% | −237.4% | −176.3% | −217.9% |
| Diluted EPS | $-0.27 | $-0.31 | $-0.28 | $-0.26 | $-0.27 | $-0.26 | $-0.22 | $-0.26 | $-0.29 | $-0.31 | $-0.26 | $-0.31 |
| EBITDA | -$11.6M | -$13.1M | -$11.4M | -$10.6M | -$11.3M | -$10.8M | -$9.4M | -$11.2M | -$12.6M | -$13.5M | -$11.4M | -$13.7M |
| Operating cash flow | -$12.7M | -$15.1M | -$3.2M | -$9.1M | -$9.7M | -$9.1M | -$9.9M | -$8.6M | -$10.1M | -$15.5M | -$9.5M | -$9.7M |
| Free cash flow | -$12.9M | -$15.5M | -$3.3M | -$9.1M | -$10.1M | -$9.4M | -$10.0M | -$8.8M | -$10.6M | -$16.1M | -$9.9M | -$10.2M |
| Diluted shares | 48.3M | 45.4M | 45.1M | 45.0M | 44.6M | 44.0M | 43.8M | 43.7M | 43.6M | 43.2M | 43.1M | 43.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.7M | $13.8M | $20.0M | $18.9M | $18.3M | $18.9M |
| Short-term investments | $5.1M | $9.1M | $18.3M | $22.3M | $12.9M | $22.8M |
| Total debt | $19.1M | $19.1M | $18.9M | $18.8M | $0.00 | $0.00 |
| Total assets | $58.5M | $62.4M | $74.9M | $84.4M | $75.6M | $85.4M |
| Total liabilities | $40.7M | $42.0M | $41.6M | $40.1M | $21.0M | $19.9M |
| Shareholders' equity | $17.7M | $20.4M | $33.2M | $44.3M | $54.5M | $65.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology